ARVN.NASDAQArvinas, INC

Form 4: Arvinas Inc. Chief Medical Officer Noah Berkowitz Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Noah Berkowitz, Chief Medical Officer of Arvinas Inc., sold 8,658 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On March 18, 2025, Noah Berkowitz, the Chief Medical Officer of Arvinas Inc., sold 8,658 shares of the company's common stock.
  • The sale was executed at a price of $8.59 per share.
  • This transaction was conducted automatically by Arvinas Inc. to cover tax withholding obligations associated with the vesting and settlement of 25% of Berkowitz's restricted stock units (RSUs) granted on March 18, 2024.
  • Following the transaction, Berkowitz directly owns 110,023 shares of Arvinas Inc. common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any particular positive or negative sentiment towards the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction reflects a standard part of executive compensation and equity management.

Stakeholder Impact

  • The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial health.

Key Dates

DateDescription
03/18/2024Date of grant for restricted stock units (RSUs) that triggered the tax obligation.
03/18/2025Date of the stock sale to cover tax withholding obligations.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.